End-Stage Renal Disease Clinical Trial
Official title:
Potential Role of Gum Arabic as Antioxidant and Anti-inflammatory Agent in Hemodialysis Patients
Oxidative processes increased in patients with renal failure and especially patients with end stage renal failure on dialysis. Oxidative stress plays a role in renal damage and also on cardiovascular disease, atherosclerosis, which can accelerate renal damage. Gum Arabic is claimed to have antioxidant effect and this will decrease the harmful effect of the free radical on patient on hemodialysis. In this study investigators are aiming to see the effect of Gum Arabic on Oxidative Stress and inflammatory markers in patients on regular hemodialysis.
The oxidative stress reflects an imbalance between the systemic manifestation of reactive
oxygen species and a biological system's ability to readily detoxify the reactive
intermediates or to repair the resulting damage.
Cells continuously produce free radicals and reactive oxygen species (ROS) as part of
metabolic processes. These free radicals are neutralized by an elaborate antioxidant defense
system consisting of enzymes such as catalase, superoxide dismutase, glutathione peroxidase,
and numerous non-enzymatic antioxidants, including vitamins A, E and C and glutathione.
Oxidative stress has been linked to the pathogenesis of a variety of diseases, such as renal
disease, cardiovascular disease, atherosclerosis, hypertension, cancer, diabetes, arthritis
neurodegenerative diseases (i.e., Alzheimer's and Parkinson's disease), and aging.
The prevalence and incidence of patient suffering from chronic renal failure is increasing
worldwide and locally in Sudan(5). Several publication suggest that oxidative processes may
be increased in patients with renal failure. As oxidative stress plays a role in renal damage
it offers a potential target for therapeutic intervention.
There is a lot of factors that can lead to oxidative stress in patients with chronic kidney
disease (CKD) . Intravenous administration of iron is widely prescribed in patients with
chronic kidney disease (CKD) and can cause oxidative stress.Hemodialysis is often used for
removal of excessive toxins, metabolic products, and blood components from patients with
end-stage renal diseases (ESRD). Clinical studies have confirmed that hemodialysis (HD) is
associated with the development of oxidative stress and disturbance in the enzyme systems
that protect against oxygen free radicals.
The major cause of mortality in patients with end-stage renal failure receiving renal
replacement therapy is cardiovascular disease . Cardiovascular disease (CVD) is the cause of
death in 34% of hemodialysis (HD) patients. Increased lipid peroxidation and depletion of
chain- breaking antioxidants may contribute to increased risk of atherosclerosis.
Antioxidants have been used as therapies to decrease oxidative stress and improve CVD risk in
hemodialysis (HD) Patients .Many studies investigated the effects of antioxidant therapies on
biomarkers of oxidative stress or clinical outcomes. The majority were small trials using a
nonrandomized open-label design with a single HD group (no HD controls). The antioxidant used
were Alpha-tocopherol , vitamin c decreased oxidative stress and N-acetylcysteine .
N-acetylcysteine was the most efficacious agent. Others studies have used a combination of
antioxidants that decreased oxidative stresses. Most of these intervention studies were done
in HD patients .
Gum arabic is defined by the FAO/WHO Joint Expert Committee for Food Additives (JECFA) as 'a
dried exudation obtained from the stems of Acacia Senegal tree or closely related species of
Acacia (family Leguminosae).
GA is indigestible for both human and animals; Its fermentation by colonic intestinal
bacteria leads to formation of various degradation products, such as short-chain fatty acids
.Gum Arabic ingestion increases serum short chain fatty acid concentration, mainly butyrate
and propionate. Serum butyrate concentration increased following administration of GA in
healthy subjects. Oral intake of GA has been shown to provide several health benefits, such
as prebiotic effects. GA significantly increases Bifidobacteria, Lactobacteria, and
Bacteriodes in the gut. GA is claimed to have anti-cancer ,anti-malarial immune-modulatory
and antioxidant effects. GA treatment has been shown to favorably influence clinical and
laboratory results in rats with adenine-induced chronic renal failure CRF and in humans
diagnosed with renal failure, reported that GA was able to decrease high levels of several
pro-inflammatory cytokines in plasma and kidney of rats suffering from adenine-induced CRF.
The antioxidant effect of Gum Arabic has been observed in Number of published data .
More recently 2017 reported more evidence that GA has potent anti- oxidative effects in
humans as demonstrated by its ability to increase TAC and to decrease oxidative stress
markers in humans, Almost all previous studies were conducted in animal models or in vitro
studies except the last one(17) . the increased intake of dietary antioxidants from GA may
help to maintain an adequate antioxidant defense status . GA can be utilized in other
clinical conditions and diseases caused by increased lipid peroxidation and tissue injury.
In this study investigators are aiming to see the effect of Gum Arabic on Oxidative Stress
and inflammatory markers in patients on regular hemodialysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04087213 -
Study of HemoCareā¢ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD
|
N/A | |
Completed |
NCT02207088 -
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
|
Phase 3 | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Completed |
NCT02237521 -
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
|
N/A | |
Withdrawn |
NCT01691196 -
Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
|
||
Completed |
NCT01394341 -
Liraglutide Treatment to Patients With Severe Renal Insufficiency
|
Phase 4 | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT00307463 -
Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
|
Phase 4 | |
Recruiting |
NCT00155363 -
Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
|
Phase 4 | |
Completed |
NCT00234156 -
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
|
N/A | |
Completed |
NCT00586131 -
Arterial pH and Total Body Nitrogen Balances in APD
|
Phase 4 | |
Active, not recruiting |
NCT05027074 -
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
|
Phase 2 | |
Recruiting |
NCT04575077 -
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
|
||
Enrolling by invitation |
NCT05001009 -
Goals of Care Conversations Study
|
N/A | |
Completed |
NCT01756508 -
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Terminated |
NCT03661229 -
Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
|
N/A | |
Completed |
NCT03288922 -
Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF
|
N/A | |
Completed |
NCT02572882 -
Gut Microbiome and p-Inulin in Hemodialysis
|
N/A | |
Completed |
NCT02360748 -
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
|
N/A |